Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.
4.

Double-blind, placebo-controlled study of S-adenosyl-L-methionine in depressed postmenopausal women.

Salmaggi P, Bressa GM, Nicchia G, Coniglio M, La Greca P, Le Grazie C.

Psychother Psychosom. 1993;59(1):34-40.

PMID:
8441793
5.

Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.

Freeman MP, Mischoulon D, Tedeschini E, Goodness T, Cohen LS, Fava M, Papakostas GI.

J Clin Psychiatry. 2010 Jun;71(6):682-8. doi: 10.4088/JCP.10r05976blu.

PMID:
20573327
6.

Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial.

Kagan BL, Sultzer DL, Rosenlicht N, Gerner RH.

Am J Psychiatry. 1990 May;147(5):591-5.

PMID:
2183633
7.

Comparison between the antidepressant activity and of S-adenosylmethionine (SAMe) and that of some tricyclic drugs.

Miccoli L, Porro V, Bertolino A.

Acta Neurol (Napoli). 1978 May-Jun;33(3):243-55. No abstract available.

PMID:
371351
8.

Rapidity of onset of the antidepressant effect of parenteral S-adenosyl-L-methionine.

Fava M, Giannelli A, Rapisarda V, Patralia A, Guaraldi GP.

Psychiatry Res. 1995 Apr 28;56(3):295-7.

PMID:
7568552
9.

Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.

Tollefson GD, Holman SL, Sayler ME, Potvin JH.

J Clin Psychiatry. 1994 Feb;55(2):50-9.

PMID:
8077155
10.

S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response.

Sarris J, Papakostas GI, Vitolo O, Fava M, Mischoulon D.

J Affect Disord. 2014 Aug;164:76-81. doi: 10.1016/j.jad.2014.03.041. Epub 2014 Apr 1.

PMID:
24856557
11.

Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature.

Altshuler LL, Bauer M, Frye MA, Gitlin MJ, Mintz J, Szuba MP, Leight KL, Whybrow PC.

Am J Psychiatry. 2001 Oct;158(10):1617-22.

PMID:
11578993
12.

Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine.

Berlanga C, Ortega-Soto HA, Ontiveros M, Senties H.

Psychiatry Res. 1992 Dec;44(3):257-62.

PMID:
1289923
13.

Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder.

Papakostas GI.

J Clin Psychiatry. 2009;70 Suppl 5:18-22. doi: 10.4088/JCP.8157su1c.04. Review.

PMID:
19909689
14.

The antidepressant potential of oral S-adenosyl-l-methionine.

Rosenbaum JF, Fava M, Falk WE, Pollack MH, Cohen LS, Cohen BM, Zubenko GS.

Acta Psychiatr Scand. 1990 May;81(5):432-6.

PMID:
2113347
15.

A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.

Lydiard RB, Stahl SM, Hertzman M, Harrison WM.

J Clin Psychiatry. 1997 Nov;58(11):484-91.

PMID:
9413414
16.

Early clinical double-blind study with S-adenosyl-L-methionine: a new potential antidepressant.

Küfferle B, Grünberger J.

Adv Biochem Psychopharmacol. 1982;32:175-80. No abstract available.

PMID:
7046363
18.

Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence.

Mischoulon D, Fava M.

Am J Clin Nutr. 2002 Nov;76(5):1158S-61S. Review.

19.

Affective illness and S-adenosyl methionine: a preliminary report.

Carney MW, Edeh J, Bottiglieri T, Reynolds EM, Toone BK.

Clin Neuropharmacol. 1986;9(4):379-85.

PMID:
2425961
20.

The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis.

Mittmann N, Herrmann N, Einarson TR, Busto UE, Lanctôt KL, Liu BA, Shulman KI, Silver IL, Narango CA, Shear NH.

J Affect Disord. 1997 Dec;46(3):191-217.

PMID:
9547117
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk